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Purpose: to assess among current smokers in Switzerland the willingness to quit and the 
preferred methods to help quitting smoking. 
Methods: cross-sectional study including 1265 current smokers (607 women and 658 men). 
Difficulty quitting smoking and the preferred methods to help quitting smoking were assessed by 
questionnaire. 
Results: 89% of women and 84% of men reported being "very difficult" or "difficult" to quit 
smoking. Almost three quarters of smokers (73% of women and 70% of men) reported some 
willingness to quit smoking, but less than 25% of them wanted to do so within the next 30 days, 
and only 64% within the next 6 months. Willingness to quit was stronger among younger smokers 
while no differences were found for gender, physical activity or education al Javel. The preferred 
methods to help quitting smoking were personalized counselling by a doctor (51.4%), acupuncture 
(35.9%); nicotine replacement therapy (37.6%); hypnosis (28.8%); information flyers (24.9%); 
autogenic training (15.3%); bupropion (15.2%); personalized counselling by a non-doctor (14.7%) 
and group interventions (13.2%). Acupuncture and hypnosis were more favoured by women, and 
autogenic training by younger smokers. Still, a sizable fraction (between 19 and 51%) of smokers 
did not know some of the methods to help quitting smoking. 
Conclusion: although more than two thirds of Swiss smokers want to quit, only a small fraction 
wishes to do so in the short term. Setter information regarding the different methods to help 
quitting is also necessary. 
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